Johnson & Johnson Stock News

Johnson & Johnson won a federal judge’s permission to continue with its controversial strategy to force a settlement with people who claim the company’s baby powder gave them cancer.

MADISON, Wis. – Attorney General Kaul announced today the final approval of the $26 billion opioid agreement with the nation’s three major pharmaceutical distributors – Cardinal, McKesson, and AmerisourceBergen – and Johnson & Johnson. Following successful state sign-on and subdivision sign-on periods, the defendants will start releasing funds to a national administrator on April 2, […]

Distributors McKesson Corporation (NYSE: MCK ), AmerisourceBergen Corp (NYSE: ABC ), Cardinal Health Inc (NYSE: CAH ), and Johnson & Johnson (NYSE: JNJ ) have agreed to finalize a proposed $26 billion settlement resolving claims by states and local governments regarding the opioid epidemic. The deal aims to resolve more than 3,000 lawsuits, mainly by state and local governments seeking to hold the companies responsible for … Full story available on Benzinga.com

A U.S. judge ruled on Friday that a Johnson & Johnson subsidiary can remain in bankruptcy, preventing plaintiffs from pursuing 38,000 lawsuits against the company alleging its baby powder and other talc products cause cancer.

Shares of Johnson & Johnson slipped 1.91% to $158.14 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P…

German Health Insurer Reveals ''Alarming'' Underreporting Of Vaccine Side-Effects A large German health insurance provider revealed on Wednesday that Covid-19 vaccine side-effects are vastly underreported, according to Welt . After analyzing data from over 10 million individuals, BKK ProVita board member Andreas Schöfbeck, over a 7.5 month period beginning in early 2021, 216,695 policyholders out of 10.9 million were treated for vaccine side-effects. This compares to 244,576 reports out of 61.4 million reported by the Paul Ehrlich Institute - a German federal agency. Germany has a population of around 83 million people. Schöfbeck called the data an "alarm signal," adding "The numbers determined are significant and urgently need to be checked for plausibility." " The data available to our company gives us reason to believe that there is a very considerable under-recording of suspected cases of vaccination side-effects after they received the [COVID-19] vaccine. " “If these figures are applied to the year as a whole and to” the entire population of Germany, Schöfbeck estimated, then “ probably 2.5-3 million people in Germany been under medical treatment because of vaccination side effects after [COVID-19] vaccination. ” As Jack Phillips of The Epoch Times notes: Schöfbeck concluded that based on their data, “there is a significant underreporting of vaccination side-effects ” in Germany.

WASHINGTON, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Fragrance Creators Association and 35 other cosmetics and personal care companies, as well as industry trade associations, have joined forces to create the EcoBeautyScore Consortium. The Consortium is made up of small and large companies and associations from four continents. The 36 Consortium members include: Amorepacific, Babor, Beiersdorf, Colgate-Palmolive, Cosmébio, COSMED, Cosmetic Valley, Cosmetics Europe, cosnova, Coty, The Estée Lauder Companies, Eugène Perma, FEBEA, Fragrance Creators Association, Henkel, IKW Beauty Care, The International Fragrance Association, Johnson & Johnson Consumer Inc., JUST International AG, Kao, L''Oréal Groupe, LVMH, Nafigate, NAOS, Natrue, Natura &Co, NOHBA, Oriflame, P&G, Paragon Nordic, Puig, PZ Cussons, Shiseido, Sisley, STANPA, and Unilever. The purpose of the EcoBeautyScore Consortium is to enable consumers to make sustainable choices through an environmental impact assessment and scoring system. The Consortium is working to develop an industry-wide environmental impact assessment and scoring system for cosmetics.

US drug maker Johnson & Johnson says it is close to clinching a vaccine licence deal with South African group Aspen Pharmacare.

NORTH BETHESDA, Md. , Feb. 23, 2022 /PRNewswire-PRWeb/ -- The International Society for Pharmaceutical Engineering (ISPE) announced three keynote presenters for the 2022 ISPE Aseptic Conference , taking place 14–15 March 2022 in North Bethesda, Maryland and virtually. Now in its 31st year, this signature event has established itself as the pharmaceutical industry''s leading source on advancing aseptic and barrier operations and providing invaluable opportunities for peer-to-peer learning through interactions with industry and regulatory leaders. This year''s event features a dynamic line-up of thought-provoking keynote presentations led by prominent leaders in the pharmaceutical industry. Confirmed Keynote Presenters: Alonza Cruse , Director, Office of Pharmaceutical Quality Operations FDA/ORA Presentation title: "ORA Update – Navigating our Oversight through COVID-19 and Beyond" Alonza Cruse is director of the Office of Pharmaceutical Quality Operations within the Office of Regulatory Affairs (ORA) in the Food and Drug Administration (FDA).

US drug maker Johnson & Johnson says it is close to clinching a vaccine licence deal with South African group Aspen Pharmacare.

Osagie Ehanire, Minister for Health, has expressed concern that the number of Nigerians who have been fully vaccinated is still very low because the country has been administering double dose vaccines. The minister decried that most persons who have received their first dose are reluctant to take their second dose for various reasons including fear of a repeat of the mild side effects they may have experienced with the first dose. The minister raised this concern during the launch of SCALES 2.0 strategy, which stands for Service delivery, Communication, Accountability, Logistics, Electronic Reporting, and Supportive Supervision to scale up COVID-19 vaccination organised by the National Primary Health Care Development Agency (NPHCDA). Ehanire disclosed that as of 18th February, Nigeria has administered over 20million doses, representing over 18 percent of the 111,176,503 eligible population targeted for COVID-19 vaccination. THE minister, however, assured that the federal government have over 30 million doses of teh Johnson and Johnson vaccine stock, which is a single-dose vaccine and urged Nigerians to show up for vaccination.

A new market research report published by Business Market Insights (BMI), a leading market research firm, today released a report titled "North America Allergy Immunotherapies Market". This report presents a new perspective on the opportunities and challenges in the significantly

Pune, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Global Beauty and Personal Care market report is expert study that can deliver you with an elaborate analysis of the Beauty and Personal Care. The report covers information about top players, projected size of the market, data and figures to update about where opportunities are in the market, competitor analysis and vendor information. Also, it offers a complete analysis of the key market dynamics, with growth drivers, challenges, restraints, opportunities and trends. Furthermore, receive exact details and statistics associated to Beauty and Personal Care market and its key factors such as revenue, growth, compound annual growth, year-over-year developments, consumption, and production. Get a Sample Copy of the Report at - https://www.absolutereports.com/enquiry/request-sample/20028468 The global Beauty and Personal Care market size is estimated to be worth USD 455300 million in 2021 and is forecast to a readjusted size of USD 639650 million by 2028 with a CAGR of 5.0% during review period.

Attorneys for Johnson & Johnson (JNJ) that plaintiffs attorneys dont agree with the companys bankruptcy plan because they want more money.